PR3-AAV Resilient Remission or PRRR
Condition(s):Granulomatosis With Polyangiitis; Microscopic Polyangiitis; ANCA Associated VasculitisLast Updated:November 13, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Granulomatosis With Polyangiitis; Microscopic Polyangiitis; ANCA Associated VasculitisLast Updated:November 13, 2023Recruiting
Condition(s):ANCA Associated Vasculitis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Wegener GranulomatosisLast Updated:August 28, 2023Recruiting
Condition(s):Lupus Erythematosus; Systemic Lupus Erythematosus; SLE (Systemic Lupus); Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Granulomatous Polyangiitis; Microscopic PolyangiitisLast Updated:March 8, 2024Not yet recruiting
Condition(s):Sepsis; Pre-Eclampsia; Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Adiposity; SIRS; ProcalcitoninLast Updated:January 30, 2023Recruiting
Condition(s):Wegeners Granulomatosis (Granulomatosis With Polyangiitis); Microscopic Polyangiitis; Eosinophilic Granulomatosis With Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis; Primary CNS Vasculitis; Unclassified VasculitisLast Updated:November 30, 2023Recruiting
Condition(s):Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss); Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener’s); Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu’s ArteritisLast Updated:May 26, 2023Recruiting
Condition(s):Eosinophilic Granulomatosis With Polyangiitis (EGPA); Churg-Strauss Syndrome (CSS); Giant Cell Arteritis; Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu ArteritisLast Updated:December 20, 2023Recruiting
Condition(s):Aortitis; Cutaneous Vasculitis; Eosinophilic Granulomatosis With Polyangiitis; Giant Cell Arteritis; Granulomatosis With Polyangiitis (Wegener’s); Henoch-Schonlein Purpura; IgA Vasculitis; Microscopic Polyangiitis; Polyarteritis Nodosa; Takayasu Arteritis; Churg-Strauss SyndromeLast Updated:January 25, 2024Recruiting
Condition(s):Cryoglobulinemic Vasculitis (CV); Drug-induced Vasculitis; Eosinophilic Granulomatosis With Polyangiitis (EGPA); IgA Vasculitis; Isolated Cutaneous Vasculitis; Granulomatosis With Polyangiitis (GPA); Microscopic Polyangiitis (MPA); Polyarteritis Nodosa (PAN); Urticarial Vasculitis; VasculitisLast Updated:January 25, 2024Recruiting
Condition(s):Vasculitis; Behcet’s Disease; CNS Vasculitis; Cryoglobulinemic Vasculitis; Eosinophilic Granulomatosis With Polyangiitis (EGPA); Churg-Strauss Syndrome (CSS); Granulomatosis With Polyangiitis (GPA); Wegener’s Granulomatosis; IgA Vasculitis; Henoch-Schoenlein Purpura (HSP); Microscopic Polyangiitis (MPA); Polyarteritis Nodosa (PAN); Takayasu Arteritis (TAK); Urticarial Vasculitis; Systemic VasculitisLast Updated:May 30, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.